Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of apremilast in Japan
jRCT2080224847Phase 2Completed
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of apremilast. Started Aug 2019; status: completed.
02
Drugs
apremilast
Beyond the preview
Go deeper on jRCT2080224847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224847.